Attorneys: Pre-emption ambiguous for drug-device combination products

03/18/2008 | Medical Devices Today

Plaintiffs' attorneys contend that drug-device combination products should not be eligible for federal pre-emption under the the Food, Drug and Cosmetic Act. "There is plenty of room yet to wiggle and combination products provide that wiggle room," said one attorney for pharmaceutical and device companies.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD